Association of Corporate Counsel
Member Login
By in-house counsel, for in-house counsel ®
Search Filters
2 pages
The presence of private equity (PE) investment has exploded in recent years in all areas of the health care sector. PE in health care is a good thing when done right: It can pave the way for much needed innovation, efficiency, and nontraditional care delivery models. However, government regulators, media journalists, some health care practitioners, and private parties are watching PE investment with growing suspicion that profit-driven goals may conflict with the quality of care for patients.
Resource Details
Interest Area:
Health Law
Region:
United States
Audience:
Mid-Career, New to In-House, Small Law Departments, Large Law Departments
1 pages
The Personalized Medicine Coalition (PMC) recently released its annual report on the progress of precision medicine as measured by precision medicine FDA approvals in 2022 (“Report”). As summarized in the Report, 2022 milestones include progress in diagnostics, therapeutics and new treatment modalities that are covered in this resource from Foley and Lardner LLP.
Resource Details
Interest Area:
Health Law
Region:
United States
Audience:
Mid-Career, New to In-House, Small Law Departments, Large Law Departments
2 pages
With the pandemic, there came a digital health explosion, with companies working swiftly to bring new technologies to light that would pave the way forward in telehealth and other critical areas. We saw an incredible interest in this space then, but what is the state of digital health now? This resource from Foley & Lardner LLP looks at data from public and private financing markets in the digital health space in 2022, and look forward to what to expect in 2023.
Resource Details
Interest Area:
Health Law
Region:
United States
Audience:
Mid-Career, New to In-House, Small Law Departments, Large Law Departments
4 pages
With the health care industry under pressure to improve patient outcomes while controlling costs, artificial intelligence (AI) and machine learning (ML) are quickly becoming indispensable tools. These technologies show promise in supporting decision-making, enhancing the delivery of care, and personalizing medicine. This resource from Foley & Lardner explores opportunities for health care organizations deploying AI-based solutions.
Resource Details
Interest Area:
Health Law
Region:
United States
Audience:
Mid-Career, New to In-House, Small Law Departments, Large Law Departments
2 pages
This resource provided by Foley & Lardner LLP covers the DOJ’s announcement on February 6th of their withdrawal of the 2011 Statement of Antitrust Enforcement Policy Regarding Accountable Care Organizations Participating in the Medicare Shared Savings Program (2011 ACO Statement) in addition to two other health care antitrust policy statements.
Resource Details
Interest Area:
Health Law
Region:
United States
Audience:
Mid-Career, New to In-House, Small Law Departments, Large Law Departments
32 pages
This resource from Foley and Lardner provides insight into the most prominent trends throughout 2023. These trends are focused on the health care and life sciences sector.
Resource Details
Interest Area:
Health Law
Audience:
Mid-Career, New to In-House, Small Law Departments, Large Law Departments
16 pages
This guide provided by Foley & Lardner summarizes the key elements and requirements contained in the proposed rule. In addition it explains how it differs from the special telemedicine registration rule. Finally, it describes what stakeholders can do to make their voice heard, including by submitting comments to the proposed rule, during these next 30 days.
Resource Details
Interest Area:
Health Law
Region:
United States
Audience:
Mid-Career, New to In-House, Small Law Departments, Large Law Departments